488 related articles for article (PubMed ID: 12875699)
1. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Zhao J; Hu J; Cai J; Yang X; Yang Z
Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
[TBL] [Abstract][Full Text] [Related]
2. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
Zhao J; Hu J; Cai J
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
[TBL] [Abstract][Full Text] [Related]
4. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
8. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma.
Liu Z; Yan L; Xiang T; Jiang L; Yang B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):249-50, 254. PubMed ID: 12856590
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
11. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
Xiong ZP; Yang SR; Xiao EH; Zhou SK; Zhang ZS; Liang ZY
Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
[TBL] [Abstract][Full Text] [Related]
12. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
[TBL] [Abstract][Full Text] [Related]
14. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
15. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
16. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.
Li XM; Tang ZY; Zhou G; Lui YK; Ye SL
J Exp Clin Cancer Res; 1998 Mar; 17(1):13-7. PubMed ID: 9646228
[TBL] [Abstract][Full Text] [Related]
17. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma.
Iguchi H; Yokota M; Fukutomi M; Uchimura K; Yonemasu H; Hachitanda Y; Nakao Y; Tanaka Y; Sumii T; Funakoshi A
J Exp Clin Cancer Res; 2002 Sep; 21(3):309-13. PubMed ID: 12385570
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
20. [Expression of vascular endothelial growth factor correlates with invasion and metastasis of hepatocellular carcinoma].
Li X; Tang Z; Zhou G
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):12-4. PubMed ID: 10921046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
